Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report

Published:2019-01-02 Issue:2 Volume:10 Page:347-351
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Cortellini Alessio¹²^ORCID,Verna Lucilla²,Porzio Giampiero¹²,Bozzetti Federico³,Palumbo Pierpaolo²,Masciocchi Carlo²,Cannita Katia²,Parisi Alessandro¹²,Brocco Davide⁴,Tinari Nicola⁵,Ficorella Corrado¹²

Affiliation:

1. Medical Oncology, San Salvatore Hospital; University of L'Aquila; L'Aquila Italy

2. Department of Biotechnological and Applied Clinical Sciences; University of L'Aquila; L'Aquila Italy

3. Faculty of Medicine; University of Milan; Milan Italy

4. Clinical Oncology Unit; S.S. Annunziata Hospital; Chieti Italy

5. Department of Medical, Oral and Biotechnological Sciences; University G. D'Annunzio; Chieti Italy

Funder

Consorzio Interuniversitario Nazionale per la Bio-Oncologia

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12965/fullpdf

Reference17 articles.

1. Forcing the vicious circle: Sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy;Bozzetti;Ann Oncol,2017

2. Sarcopenia in resected non-small cell lung cancer: Effect on postoperative outcomes;Nakamura;J Thorac Oncol,2018

3. Cachexia: Clinical features when inflammation drives malnutrition;Laviano;Proc Nutr Soc,2015

4. Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients;Heidelberger;Invest New Drugs,2017

5. Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy;Cortellini;Thorac Cancer,2018

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Significance of Longitudinal Psoas Muscle Loss in Predicting the Maintenance Efficacy of Durvalumab Treatment Following Concurrent Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer: A Retrospective Study;Cancers;2024-08-30

2. Effect of longitudinal changes of cachexia on the efficacy and toxicity of immune checkpoint inhibitors in esophageal squamous cell cancer (ESCC) patients;Nutrition;2024-08

3. Predictive impact of sarcopenia in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A retrospective study;Heliyon;2024-03

4. Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors;Clinical Cancer Research;2023-12-13

5. Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapy;Hepatology Communications;2023-09-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3